Rojina Ranjit, Holly Van Remmen, & Bumsoo Ahn. (2022). Acylated Ghrelin Receptor Agonist HM01 Decreases Lean Body and Muscle Mass, but Unacylated Ghrelin Protects against Redox-Dependent Sarcopenia. MDPI AG.
Chicago Style (17th ed.) CitationRojina Ranjit, Holly Van Remmen, and Bumsoo Ahn. Acylated Ghrelin Receptor Agonist HM01 Decreases Lean Body and Muscle Mass, but Unacylated Ghrelin Protects Against Redox-Dependent Sarcopenia. MDPI AG, 2022.
MLA (9th ed.) CitationRojina Ranjit, et al. Acylated Ghrelin Receptor Agonist HM01 Decreases Lean Body and Muscle Mass, but Unacylated Ghrelin Protects Against Redox-Dependent Sarcopenia. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.